TWST Earnings & Financial Statements
Twist Bioscience Corporation
$148.16
-$3.17(-2.09%)
66
Overall
60
Value
58
Tech
81
Quality
Market Cap
$9.82B
Volume
2.11M
52W Range
$23.30 - $219.71
Target Price
$138.92
TWST earnings and financial statements: Twist Bioscience Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
TWST Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $376.57M | $312.97M | $245.11M | $203.56M | $132.33M |
| Cost of revenue | $185.57M | $179.63M | $155.38M | $119.33M | $80.62M |
| Operating income | -$136.26M | -$220.83M | -$217.16M | -$234.78M | -$152.73M |
| EBITDA | -$52.10M | -$176.73M | -$174.15M | -$211.69M | -$143.91M |
| Net income | -$77.67M | -$208.73M | -$204.62M | -$217.86M | -$152.10M |
| EPS (diluted) | $-1.30 | $-3.60 | $-3.60 | $-4.04 | $-3.15 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $641.86M | $614.32M | $776.40M | $961.38M | $702.10M |
| Total liabilities | $168.90M | $141.63M | $152.97M | $171.99M | $121.28M |
| Shareholders’ equity | $472.96M | $472.69M | $623.43M | $789.38M | $580.82M |
| Cash and equivalents | $183.05M | $226.32M | $286.47M | $378.69M | $465.83M |
| Long-term debt | $61.75M | $70.22M | $79.17M | $81.27M | $53.16M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$47.63M | -$64.09M | -$142.47M | -$124.39M | -$112.24M |
| Capital expenditure | -$28.00M | -$5.08M | -$27.78M | -$101.86M | -$27.06M |
| Free cash flow | -$75.63M | -$69.17M | -$170.25M | -$226.24M | -$139.31M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TWST | $148.16 | -2.1% | 2.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Twist Bioscience Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW